Clinical Roundup MammaPrint predicts chemotherapy benefit in HR+HER2 early breast cancer patients, observational FLEX study finds September 05, 2025Vol.51 No.32
Clinical Roundup Off-the-shelf cancer vaccine elicits strong immune response in patients with pancreatic and colorectal cancer September 05, 2025Vol.51 No.32
Clinical Roundup CAR T-cell therapy clinical trial debuts at KU Cancer Center September 05, 2025Vol.51 No.32
Clinical Roundup Cancer-associated nerve injury leads to chronic inflammation and immunotherapy resistance September 05, 2025Vol.51 No.32
Clinical Roundup Decipher Prostate Test predicts chemo benefit in metastatic prostate cancer, phase III trial shows September 05, 2025Vol.51 No.32
Clinical Roundup Many patients with advanced cancer feel treatment not aligned with personal care goals, UC study shows September 05, 2025Vol.51 No.32
Clinical Roundup IO Biotech’s vaccine misses on mPFS in phase III advanced melanoma trial September 05, 2025Vol.51 No.32
Drugs & Targets FDA approves expanded indication for Avtozma intravenous formulation in cytokine release syndrome September 05, 2025Vol.51 No.32
Drugs & Targets FDA grants breakthrough designation for Rina-S in advanced endometrial cancer September 05, 2025Vol.51 No.32
